SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
20697094
Source:
http://linkedlifedata.com/resource/pubmed/id/20697094
Search
Subject
(
65
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0079773
,
umls-concept:C0205088
,
umls-concept:C0205269
,
umls-concept:C1274040
,
umls-concept:C1512888
,
umls-concept:C1527027
,
umls-concept:C2603343
pubmed:issue
29
pubmed:dateCreated
2010-10-8
pubmed:abstractText
The primary objective of this study was to confirm the efficacy of romidepsin in patients with treatment refractory cutaneous T-cell lymphoma (CTCL).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antibiotics, Antineoplastic
,
http://linkedlifedata.com/resource/pubmed/chemical/Depsipeptides
,
http://linkedlifedata.com/resource/pubmed/chemical/romidepsin
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1527-7755
pubmed:author
pubmed-author:BeckerJürgen CJC
,
pubmed-author:DemierreMarie-FranceMF
,
pubmed-author:DuvicMadeleineM
,
pubmed-author:KimEllen JEJ
,
pubmed-author:KimYoun HYH
,
pubmed-author:LernerAdamA
,
pubmed-author:McCullochWilliamW
,
pubmed-author:ReddySunilS
,
pubmed-author:RobakTadeuszT
,
pubmed-author:RookAlain HAH
,
pubmed-author:SamtsovAlexeyA
,
pubmed-author:ScarisbrickJuliaJ
,
pubmed-author:WhittakerSean JSJ
pubmed:issnType
Electronic
pubmed:day
10
pubmed:volume
28
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4485-91
pubmed:meshHeading
pubmed-meshheading:20697094-Aged
,
pubmed-meshheading:20697094-Antibiotics, Antineoplastic
,
pubmed-meshheading:20697094-Asthenia
,
pubmed-meshheading:20697094-Depsipeptides
,
pubmed-meshheading:20697094-Drug Administration Schedule
,
pubmed-meshheading:20697094-Drug Resistance, Neoplasm
,
pubmed-meshheading:20697094-Female
,
pubmed-meshheading:20697094-Humans
,
pubmed-meshheading:20697094-Infusions, Intravenous
,
pubmed-meshheading:20697094-Lymphoma, T-Cell, Cutaneous
,
pubmed-meshheading:20697094-Male
,
pubmed-meshheading:20697094-Middle Aged
,
pubmed-meshheading:20697094-Nausea
,
pubmed-meshheading:20697094-Neoplasm Staging
,
pubmed-meshheading:20697094-Prospective Studies
,
pubmed-meshheading:20697094-Skin
,
pubmed-meshheading:20697094-Skin Neoplasms
,
pubmed-meshheading:20697094-Treatment Outcome
,
pubmed-meshheading:20697094-Vomiting
pubmed:year
2010
pubmed:articleTitle
Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma.
pubmed:affiliation
Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom. sean.whittaker@kcl.ac.uk
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't
,
Multicenter Study
,
Clinical Trial, Phase II